Vivani Medical VANI Deferred Tax Assets Regulatory Assets And Liabilities
Deferred Tax Assets Regulatory Assets And Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsRegulatoryAssetsAndLiabilities.
The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's deferred tax assets regulatory assets and liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's deferred tax assets regulatory assets and liabilities?
- Vivani Medical (VANI) reported deferred tax assets regulatory assets and liabilities of $455K in Q4 2025.
- What is the long-term trend for Vivani Medical's deferred tax assets regulatory assets and liabilities?
- Over 3 years (2022 to 2025), Vivani Medical's deferred tax assets regulatory assets and liabilities has grown at a 111.6% compound annual growth rate (CAGR), from $48K to $455K.
- What does deferred tax assets regulatory assets and liabilities mean?
- This metric captures the deferred tax consequences arising from differences between the tax basis of assets and liabilities and their reported amounts in financial statements due to regulatory requirements. It provides insight into the timing differences between accounting income and taxable income as influenced by specific regulatory frameworks.